Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- Convergence of Cannabis and Psychosis on the Dopamine System April 9, 2025This cohort study investigates the association between cannabis and the midbrain dopamine pathway involved in psychosis.
- Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression April 2, 2025This comparative effectiveness study uses data from the TriNetX network to determine whether the combination of esketamine and a serotonin-norepinephrine reuptake inhibitor (SNRI) shows differences in clinical outcomes compared to esketamine and a selective serotonin reuptake inhibitor (SSRI) in patients with treatment-resistant depression.
- Functional vs Structural Cortical Deficit Pattern Biomarkers for MDD April 2, 2025This case-control study investigates if a regional homogeneity–magnetic resonance imaging cortical deficit pattern provides a more robust biomarker for major depressive disorder (MDD) than its structural counterpart and informs the underlying, regionally specific lower cerebral blood flow in this disorder.
- Should Inflammation Be a Specifier for Major Depression in the DSM-6 ? April 2, 2025This Viewpoint discusses the opportunity to include inflammatory biomarkers as specifiers for major depression in the upcoming Sixth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-6).
- Once-Weekly Semaglutide in Adults With Alcohol Use Disorder April 1, 2025This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.
JAMA Oncology Current Issue
- Errors in Results and Figure 2 March 1, 2025The Original Investigation titled “Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX,” published online January 23, 2025, contained an error in the Results section. The correct 5-year overall survival for patients who received adjuvant (m)FOLFIRINOX (a combination of leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) […]
- Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults March 1, 2025This nonrandomized clinical trial evaluates a risk-stratified, response-adapted, transplant-free approach for treatment of children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma with nivolumab plus brentuximab vedotin followed by brentuximab vedotin plus bendamustine for patients with suboptimal response and involved-site radiotherapy.
- Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors March 1, 2025This Review describes why comprehensive molecular biomarker testing is now required for the accurate diagnosis and grading and prognostication of central nervous system tumors.
- Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation March 1, 2025This randomized clinical trial evaluates the efficacy of sharing follow-up care between the specialty center and a local oncology practice after allogeneic hematopoietic cell transplantation.
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.
Recent Activities
RMEI CE Featured Activities
REGISTER TO ATTEND